High dose interferon-α-2b adjuvant treatment for melanoma:: The UK experience

被引：0
|
作者：
Katerinaki, E [1 ]
Kularatne, B [1 ]
Hambly, R [1 ]
Turner, L [1 ]
Hancock, BW [1 ]
Lorigan, P [1 ]
机构：
[1] Weston Pk Hosp, Acad Dept Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Is there a role for adjuvant high-dose interferon-α-2b in the management of melanoma?
    Sabel, MS
    Sondak, VK
    [J]. DRUGS, 2003, 63 (11) : 1053 - 1058
  • [2] Is There a Role for Adjuvant High-Dose Interferon-α-2b in the Management of Melanoma?
    Michael S. Sabel
    Vernon K. Sondak
    [J]. Drugs, 2003, 63 : 1053 - 1058
  • [3] Toxicity of adjuvant high-dose interferon-α-2b in patients with cutaneous melanoma at high risk of recurrence
    Schachter, J
    Brenner, B
    Fenig, E
    Yahav, J
    Marshak, G
    Sulkes, A
    Gutman, H
    [J]. ONCOLOGY REPORTS, 1999, 6 (06) : 1389 - 1393
  • [4] Helping melanoma patients decide whether to choose adjuvant high-dose interferon-α2b
    Hurley, KE
    Chapman, PB
    [J]. ONCOLOGIST, 2005, 10 (09): : 739 - 742
  • [5] Feasibility of high-dose interferon-α2b adjuvant therapy for high-risk resected cutaneous melanoma
    Muggiano, A
    Mulas, C
    Fiori, B
    Liciardi, G
    Pintus, M
    Tanca, L
    Tedde, A
    Turno, R
    Desogus, A
    [J]. MELANOMA RESEARCH, 2004, 14 (02) : S1 - S7
  • [6] Response to "Helping melanoma patients decide whether to choose adjuvant high-dose interferon-α2b"
    Tarhini, Ahmad A.
    Shipe-Spotloe, Janice
    DeMark, Melissa
    Agarwala, Sanjiv S.
    Kirkwood, John M.
    [J]. ONCOLOGIST, 2006, 11 (05): : 538 - 539
  • [7] Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study
    Du, Yu
    Qi, Zhonghui
    Liang, Xianbin
    Dai, Jie
    Wei, Xiaoting
    Bai, Xue
    Mao, Lili
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Wang, Xuan
    Chen, Yu
    Guo, Jun
    Si, Lu
    [J]. DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (01):
  • [8] Patterns of failure in patients with malignant melanoma treated with high-dose interferon-α2b in the adjuvant setting
    Schachter, J
    Brenner, B
    Fenig, E
    Gutman, R
    Sulkes, A
    Gutman, H
    [J]. MELANOMA RESEARCH, 2003, 13 (01) : 93 - 96
  • [9] INTERMEDIATE DOSE INTERFERON ALFA 2B (IFN ALFA 2B) IN ADJUVANT TREATMENT OF MALIGNANT MELANOMA
    Calabria, Caterina
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Blasi, Livio
    Stefano, Rosalba
    Agostara, Biagio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 88 - 89
  • [10] Response to "Helping melanoma patients decide whether to choose adjuvant high-dose interferon-α2b" -: In Reply
    Hurley, Karen E.
    Chapman, Paul B.
    [J]. ONCOLOGIST, 2006, 11 (05): : 539 - 540
12345